Psychedelic-medicine stocks dropped sharply early Wednesday, a day after an independent panel of Food and Drug Administration advisers said the benefits of a MDMA-assisted therapy for post-traumatic stress disorder do not outweigh its risks.
Hanesbrands’ stock soared Wednesday, after the underwear and T-shirts seller said it was selling its Champion athletic-apparel business in a deal that could be valued at up to $1.5 billion.
As Alphabet looks to fill a vacancy in its senior ranks, it’s turning to a longtime Eli Lilly veteran who helped build the healthcare company into a juggernaut.